Device Trial Radar · NCT07166133
GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
125
Planned (sponsor's estimate)
Start
Mar 2, 2026
Primary completion
Jul 2028
Study completion Mar 2036
Sponsor
- Lead sponsor
- W.L.Gore & AssociatesNot on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 10, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A prospective multi-center post-market study collecting outcomes through at least 5-years and up to 10-years post procedure for subjects treated with the TBE Device in Zone 0/1 as part of routine clinical practice.
Conditions
- Aortic Arch Dissection
- Aortic Arch Aneurysm
Interventions
GORE® TAG® Thoracic Branch EndoprosthesisDevice
Lesions in aortic arch in Zone 0 or Zone 1
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of subjects with index endovascular procedure initiated after (or following) the surgical revascularization procedureTime frame: Index Endovascular Procedure Only
- Device Technical Success (index procedure only)Time frame: Index Endovascular Procedure Only
- Lesion-related mortalityTime frame: Within 30 days of surgical revascularization or within 30 days of index endovascular procedure
8 more outcomes with a free account
Locations
25 sites in 1 country. Site status is shown where the registry gives one.
HonorHealth
Scottsdale, Arizona · Recruiting
Keck Medical Center of USC
Los Angeles, California · Recruiting
Stanford University Hospital and Clinics
Palo Alto, California · Recruiting
22 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.